Navigation Links
Perforomist Inhalation Solution data to be presented today at American Thoracic Society conference
Date:5/19/2009

dyspnea and rescue medication use were seen over tiotropium treatment alone, without any additional safety or tolerability issues.

Efficacy was measured by serial spirometry, transitional dyspnea index (TDI), rescue albuterol use and the St. George's Respiratory Questionnaire (SGRQ).

The primary efficacy endpoint was standardized absolute FEV1 AUC0-3. At Week 6 the primary efficacy endpoint was significantly improved by 192 mL compared with placebo/tiotropium (1.54 versus 1.37 L, p<0.0001). Following treatment, the mean TDI score showed a significant and clinically meaningful improvement in dyspnea in the Perforomist Inhalation Solution/tiotropium group compared with the placebo/tiotropium group, with mean TDI scores of 1.97 and 0.67, respectively (p=0.0001).

When Perforomist Inhalation Solution was added to tiotropium there was a significant decrease in the need for rescue albuterol use throughout the double-blind period compared with placebo/tiotropium (p<0.0001). SGRQ scores were similar both between treatments and to baseline, except the symptom domain score, which fell in the Perforomist Inhalation Solution/tiotropium group (-5.8) compared with placebo/tiotropium group (-1.0).

Overall, 31 percent of Perforomist Inhalation Solution/tiotropium-treated subjects experienced adverse events versus 46 percent of the placebo/tiotropium-treated subjects. COPD exacerbations were the most common adverse events, and occurred in over twice as many placebo/tiotropium-treated subjects as Perforomist Inhalation Solution/tiotropium-treated subjects. The most frequent adverse events following COPD exacerbations were acute bronchitis and upper respiratory tract infections.

"COPD patients in this analysis saw improvement in several areas when adding Perforomist Inhalation Solution to their tiotropium treatment," said Davida J. White Pettaway, M.D., Senior Manager, Medical and Scientific Affairs, Dey, L.P. "Having replicate
'/>"/>

Contact: Julie Piszczor
jpiszczor@powelltate.com
202-585-2106
Powell Tate
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008
2. Perforomist-comparable pharmacokinetic and pharmacodynamic profile to DPI formulation
3. Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD
4. U.S. Patent and Trademark Office Issues Mylans Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution
5. Dey, L.P. Highlights Perforomist(R) Inhalation Solution Data to Be Presented at the International Conference of the American Thoracic Society
6. Perforomist Inhalation Solution data to be presented at American Thoracic Society conference
7. Perforomist(R) Inhalation Solution Data in Patients With Moderate to Severe COPD to Be Presented at the International Conference of the American Thoracic Society
8. FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
9. Par Pharmaceutical Begins Shipment of Budesonide Inhalation Suspension Immediately
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 A bucket list should include ... Each item on the bucket list can be tiny, ... tasks that the owner wants to happen in their ... when it comes to making this list. Bucket ... publishing a book, seeing the Grand Canyon on horseback, ...
(Date:5/28/2015)... With the price of advanced diagnostic ... as equipment becomes more sophisticated, Cypress Benefit Administrators ... of 60% off test costs on behalf of its ... has partnered with One Call Care Management to offer ... solution for diagnostic testing while still maintaining the highest ...
(Date:5/28/2015)... First Choice Emergency Room , the largest ... States, announced that it is expanding in the Denver ... facility. , “I am pleased to announce that ... emergency medical care to Denver residents with our new ... M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:5/28/2015)... May 28, 2015 Dallas urologist ... version of his patient education website NORTHTEXASUROLOGIST.COM ... allows patients to readily access current educational information ... treatment, male urinary incontinence, prostate cancer treatment, robotic ... this website is to educate patients on urological ...
(Date:5/28/2015)... 2015 Aureus Medical Group (web: aureuslocumtenens.com), ... jobs, has announced that it will participate as an ... National Conference to be held June 9-14, 2015 in ... programming, networking opportunities, and exhibits with products and services. ... division will be available to speak with attendees ...
Breaking Medicine News(10 mins):Health News:TPA Offers Clients Solution for More Cost-Effective Diagnostic Testing, Results in Average Savings of 60% 2Health News:First Choice Emergency Room to Open New Facility in Denver, Colorado 2Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2
... report issued today identifies the enormous global impact of preterm birth ... estimated 13 million babies are born preterm each year. Newborn deaths ... under the age of five, a rise from 37 percent in ... each year, and many of these losses are linked to maternal ...
... , ... ... ... ...
... , ... International, Inc. has announced its official launch. , ... Anaheim, CA (Vocus) February 18, 2010 -- After a ... official launch. The pilot ramp-up period was designed to simultaneously test its first product ...
... ... ... ... ...
... ... ... ... ...
... limited to physical function but also extend to neurological function, ... Journals of Gerontology Series A: Biological and Medical Sciences ... a collection of ten articles highlighting new findings related to ... consequences of improved medical management of cardiovascular disease is that ...
Cached Medicine News:Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 2Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 3Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 4Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 5Health News:GREENGUARD Environmental Institute Revamps Web Site 2Health News:GREENGUARD Environmental Institute Revamps Web Site 3Health News:GREENGUARD Environmental Institute Revamps Web Site 4Health News:GREENGUARD Environmental Institute Revamps Web Site 5Health News:GREENGUARD Environmental Institute Revamps Web Site 6Health News:GREENGUARD Environmental Institute Revamps Web Site 7Health News:National Launch of Jusuru International 2Health News:National Launch of Jusuru International 3Health News:ATR: The Individual Mandate Excise Tax is a Tax 2Health News:ATR: The Individual Mandate Excise Tax is a Tax 3Health News:ATR: The Individual Mandate Excise Tax is a Tax 4Health News:ATR: The Individual Mandate Excise Tax is a Tax 5Health News:Brookdale Announces New Corporate Line of Credit 2Health News:Brookdale Announces New Corporate Line of Credit 3Health News:Brookdale Announces New Corporate Line of Credit 4Health News:Brookdale Announces New Corporate Line of Credit 5Health News:Overweight middle-aged adults at greater risk for cognitive decline in later life 2
(Date:5/28/2015)... NEW YORK , May 28, 2015  According ... 21 to acquire Omnicare for approximately $12.7 billion fits ... seek to benefit from an aging population. The U.S. ... this is expected to continue as the aging population ... including pharmacy services. The healthcare market researcher,s report, ...
(Date:5/28/2015)... , May 28, 2015 Rigel Pharmaceuticals, Inc. ... , the company,s president and chief executive officer, is scheduled ... Healthcare Conference in New York City ... To access the live audio webcast or the subsequent archived ... Rigel,s website several minutes prior to the start of the ...
(Date:5/28/2015)... Lilly and Company (NYSE: LLY ) announced today that ... to $1.6 billion aggregate principal amount (the "tender cap") of ... aggregate principal amount of the notes listed in the table ... prior to 5:00 p.m., New York City ... for the offer. The table below sets ...
Breaking Medicine Technology:Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 2Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 3Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 4Rigel to Present at Jefferies 2015 Global Healthcare Conference 2Lilly Announces the Early Results of Its Cash Tender Offer 2Lilly Announces the Early Results of Its Cash Tender Offer 3Lilly Announces the Early Results of Its Cash Tender Offer 4Lilly Announces the Early Results of Its Cash Tender Offer 5
... U.S. Food and Drug Administration today advised consumers ... not to use the product. FDA warns that ... active pharmaceutical ingredient sibutramine, a prescription-only drug which ... the product label and could harm consumers, especially ...
... 8 Synapse Biomedical Inc ... U.S. Food and Drug Administration (FDA) designation of the ... Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis ( ... experiencing chronic hypoventilation and has now submitted for Humanitarian ...
Cached Medicine Technology:FDA: Potentially Harmful Stimulant Found in Slimming Beauty Capsules 2Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 2Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 3Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 4
... ALOKAs flagship product, the Prosound ... quality and exceptional versatility in an ... 10 is the ideal system for ... OB/GYN offices, Surgical Applications, Breast Imaging, ...
The Cardiff Acuity Test is designed specifically for,acuity measurement in children aged 1 to 3 years. The,test is also helpful with other age groups with,intellectual impairment, dementia, hea...
... performance portable ultrasound design provides unique ... Echocardiography (ultrasound) imaging requires superior ... sensitive Doppler performance. The Terason ... proprietary Teratech Architecture, delivers a portable ...
The Polygraf ID multi-parametric recorder works with POLYGRAM NET analysis software to create a unique interface that combines web-style navigation, graphical presentation and intuitive design to del...
Medicine Products: